Scholarlink

Objectives <p>This study aimed to provide Chinese data on Days Alive and Out of Hospital (DAOH) following video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy.</p> Methods <p>The analyzed data was derived from a prospective cohort study. Consecutive patients who underwent either VATS lobectomy or segmentectomy from April 2021 to July 2022 were included. The primary outcome was DAOH within the first 90 days postoperatively (DAOH90). The secondary outcomes were identifying the predominant complications and reasons for readmission during the DAOH90. Additionally, we utilized multivariate logistic regression to identify factors independently associated with decreased DAOH90.</p> Results <p>A total of 919 primary lung cancer patients were included. The median DAOH90 was 86 days (IQR, 85–87). The predominant postoperative complications within postoperative 90 days (POD90) were pneumonia (22.5%), pleural pneumothorax (15.8%), incision dehiscence (13.8%) and pleural effusion (12.8%). The primary causes of readmission in POD90 included pleural effusion (10 cases), pneumonia (7 cases), and incision dehiscence (4 cases). Age (<i>P</i> &lt; .001), operative time (<i>P</i> &lt; .001), operative bleeding (<i>P</i> = .023) and multiportal VATS (compared with robot-assisted VATS) were independently associated with decreased DAOH90.</p> Conclusions <p>In this study, the median DAOH90 following VATS lobectomy or segmentectomy was 86 days. Advanced age, longer surgical duration, more operative bleeding and multiportal VATS may be independent risk factors for “low DAOH90.”</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Days alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月6日

查看全文
  • Wenwu Liu,
  • Yadi Zhang,
  • Cheng Lei,
  • Xin Gao,
  • Yingzhi Zhao,
  • Kaixin Zhang,
  • Kui Gao,
  • Ding Yang,
  • Hongfan Yu,
  • Wei Dai,
  • Qiang Li,
  • Qiuling Shi,
  • Xing Wei

摘要

Objectives

This study aimed to provide Chinese data on Days Alive and Out of Hospital (DAOH) following video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy.

Methods

The analyzed data was derived from a prospective cohort study. Consecutive patients who underwent either VATS lobectomy or segmentectomy from April 2021 to July 2022 were included. The primary outcome was DAOH within the first 90 days postoperatively (DAOH90). The secondary outcomes were identifying the predominant complications and reasons for readmission during the DAOH90. Additionally, we utilized multivariate logistic regression to identify factors independently associated with decreased DAOH90.

Results

A total of 919 primary lung cancer patients were included. The median DAOH90 was 86 days (IQR, 85–87). The predominant postoperative complications within postoperative 90 days (POD90) were pneumonia (22.5%), pleural pneumothorax (15.8%), incision dehiscence (13.8%) and pleural effusion (12.8%). The primary causes of readmission in POD90 included pleural effusion (10 cases), pneumonia (7 cases), and incision dehiscence (4 cases). Age (P < .001), operative time (P < .001), operative bleeding (P = .023) and multiportal VATS (compared with robot-assisted VATS) were independently associated with decreased DAOH90.

Conclusions

In this study, the median DAOH90 following VATS lobectomy or segmentectomy was 86 days. Advanced age, longer surgical duration, more operative bleeding and multiportal VATS may be independent risk factors for “low DAOH90.”